Anticoagulant vs placebo or no intervention: Clinically relevant non‐major bleeding Treatment duration 28 ‐ 42 days
Anticoagulant leads to higher clinically relevant non‐major bleeding ( compared with no intervention or placebo (high certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Anticoagulant vs no intervention or placebo Clinically relevant non‐major bleeding ( · people with distal DVT Anticoagulant leads to higher clinically relevant non‐major bleeding ( compared with no intervention or placebo (high certainty). Treatment of distal deep vein thrombosis (2020) · Cochrane Headline outcomes only | RR 3.34 [1.07, 10.46] | 2 studies · 322 participants | High |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Treatment of distal deep vein thrombosis 2020 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.